Translational Development Acquisition (TDACW) Other Operating Expenses (2023)
Translational Development Acquisition's (TDACW) quarterly Other Operating Expenses came in at $485550.0 in Q4 2023.
Powered by 
Analysis
Translational Development Acquisition (TDACW) Other Operating Expenses (2023) Analysis & Trends
Translational Development Acquisition (TDACW) has reported Other Operating Expenses for 1 consecutive years, with $485550.0 the latest figure, recorded in Q4 2023.
- For the quarter ending Q4 2023, Other Operating Expenses changed N/A year-over-year to $485550.0; the trailing twelve-month figure through Mar 2025 stood at $485550.0 (changed N/A YoY), and the FY2023 full-year result was $485550.0, changed N/A from the prior year.
- Other Operating Expenses held at $485550.0 in Q4 2023 per TDACW's latest filing.
- Across five years, Other Operating Expenses topped out at $485550.0 in Q4 2023 and bottomed at $485550.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Evercore | 11.52 Bn | 9.43 Bn | 975.67 Mn |
| 2 | Jefferies Financial | 11.24 Bn | -4.17 Bn | 3.09 Bn |
| 3 | Houlihan Lokey | 9.53 Bn | 8.45 Bn | - |
| 4 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - |
| 5 | PJT Partners | 6.94 Bn | 6.99 Bn | 481.98 Mn |
| 6 | Moelis | 6.06 Bn | 5.99 Bn | - |
| 7 | Piper Sandler Companies | 5.20 Bn | 5.09 Bn | - |
| 8 | Lazard | 4.97 Bn | 3.99 Bn | - |
| 9 | BRBI BR Partners | 3.44 Bn | 3.32 Bn | 16.77 Mn |
| 10 | Translational Development Acquisition | 52.67 Mn | 52.58 Mn | - |